NCT04942860View on ClinicalTrials.gov

The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 1, 2023

Study Completion Date

August 31, 2023

Conditions
Non-segmental Vitiligo
Interventions
DRUG

1% Methotrexate gel

1% methotrexate gel applied onto a predefined limb

DRUG

0.5% Methotrexate gel

0.5% methotrexate gel applied onto a predefined limb

Trial Locations (1)

85094

Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz

All Listed Sponsors
lead

Nicolaus Copernicus University

OTHER

NCT04942860 - The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo | Biotech Hunter | Biotech Hunter